Patent · US Active

Pharmaceutical compositions comprising colloidal silicon dioxide

US8617598B2 · kind B2 · utility

11Cited by

6References

6Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Barbara Haeberlin · Riehen, CH
Andrea Kramer · Stockdorf, DE
Silvia Heuerding · Basel, CH

Key dates

Filing date	Jun 5, 2012
Grant date	Dec 31, 2013
Priority date	—
Expiry date	Jun 5, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2077
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.